Shares outstanding increased 38.1%
Shares outstanding changed +38.1% from the comparable as-filed period. The change ranks at the 75th percentile of 8 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Shares outstanding changed +38.1% from the comparable as-filed period. The change ranks at the 75th percentile of 8 prior comparable changes.
Operating income changed -23.4% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Cash & equivalents changed +143.2% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Research & development changed +88.1% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Stock-based compensation changed -51.4% from the comparable as-filed period.
Operating cash flow changed +7.9% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Current assets changed +18.5% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Total assets changed +7.7% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.